» Articles » PMID: 11402327

The 'wildtype' Conformation of P53: Epitope Mapping Using Hybrid Proteins

Overview
Journal Oncogene
Date 2001 Jun 13
PMID 11402327
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The function of p53 correlates with its 'wildtype' conformation, specifically recognized by antibodies PAb1620 and PAb246, and many cancer-associated mutations cause loss of this conformation. The epitopes of these antibodies were identified using hybrid p53 proteins created by a new method. Plasmids carrying homologous genes cut at appropriate sites recombined efficiently when transformed into RecE(+) E. coli. PAb1620 and PAb246 recognize mouse but not chicken p53; we created mouse-chicken hybrids of the p53 core domain and tested antibody reactivity. PAb246 binding mapped to residues 201-212, while PAb1620 required both residues 145-157 and 201-212 (human p53 numbering used throughout). An alanine-scan showed that the key residues for PAb246 and PAb1620 are completely distinct: PAb246 recognizes residues 202-204 (Tyr-Pro-Glu) while PAb1620 recognizes residues Arg156, Leu206, Arg209, and Gln/Asn210, the last two residues being essential. Both antibody epitopes are far from the p53 interface with DNA, but near the epitope of the 'mutant' conformation antibody PAb240. These epitope locations may help in dissecting the interactions of p53, including those with E6/E6-AP and in its DNA-bound state.

Citing Articles

Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators.

Balourdas D, Markl A, Kramer A, Settanni G, Joerger A Cell Death Dis. 2024; 15(6):408.

PMID: 38862470 PMC: 11166945. DOI: 10.1038/s41419-024-06739-x.


Biological Effects of HDAC Inhibitors Vary with Zinc Binding Group: Differential Effects on Zinc Bioavailability, ROS Production, and R175H p53 Mutant Protein Reactivation.

Flores B, Uppalapati C, Pascual A, Vong A, Baatz M, Harrison A Biomolecules. 2023; 13(11).

PMID: 38002270 PMC: 10669723. DOI: 10.3390/biom13111588.


Insights into Rational Design of a New Class of Allosteric Effectors with Molecular Dynamics Markov State Models and Network Theory.

Han I, Abramson D, Thayer K ACS Omega. 2022; 7(3):2831-2841.

PMID: 35097279 PMC: 8792916. DOI: 10.1021/acsomega.1c05624.


Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants.

Yang L, Li Y, Bhattacharya A, Zhang Y Commun Biol. 2021; 4(1):1373.

PMID: 34880421 PMC: 8655031. DOI: 10.1038/s42003-021-02880-x.


Three optimized assays for the evaluation of compounds that can rescue p53 mutants.

Wu J, Song H, Wang Z, Lu M STAR Protoc. 2021; 2(3):100688.

PMID: 34382015 PMC: 8339244. DOI: 10.1016/j.xpro.2021.100688.